JAC Advance Access originally published online on October 20, 2006
Journal of Antimicrobial Chemotherapy 2006 58(6):1307; doi:10.1093/jac/dkl417
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Comment on: Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus
1 Medical Intensive Care Unit and Emergency Department, Sahloul University Hospital Sousse, Tunisia 2 Department of Clinical Pharmacology, Faculty of Medicine of Sousse Tunisia 3 Clinique les Oliviers Sousse, Tunisia
*Corresponding author. Tel: +216-98-481-287; Fax: +216-73-367-451; E-mail: houssem_hmouda@yahoo.com
Keywords: microbial infections , trimethoprim/sulfamethoxazole , antibiotics , MRSA
| The first 10% of the full text of this article appears below. |
Sir,
We read with great interest the article written by Kaka et al.1 in the September 2006 issue of JAC. The authors clearly demonstrated that trimethoprim/sulfamethoxazole is rapidly bactericidal against methicillin-resistant Staphylococcus aureus (MRSA) in vitro when compared with most other orally available antimicrobials. No antibiotic combination exhibited better killing
Transparency declarations